Wright Medical Group
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Wright Medical Group met expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped and GAAP loss per share shrank.
Gross margins shrank, operating margins expanded, net margins expanded.
Wright Medical Group booked revenue of $110.4 million. The 14 analysts polled by S&P Capital IQ expected to see revenue of $110.9 million on the same basis. GAAP reported sales were 6.6% lower than the prior-year quarter's $118.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.04. The 14 earnings estimates compiled by S&P Capital IQ predicted -$0.05 per share. GAAP EPS were -$0.14 for Q3 versus -$0.42 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 68.2%, 120 basis points worse than the prior-year quarter. Operating margin was -3.6%, 410 basis points better than the prior-year quarter. Net margin was -4.8%, 880 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $123.1 million. On the bottom line, the average EPS estimate is $0.00.
Next year's average estimate for revenue is $483.9 million. The average EPS estimate is $0.20.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 42 members out of 59 rating the stock outperform, and 17 members rating it underperform. Among 15 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), nine give Wright Medical Group a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Wright Medical Group is outperform, with an average price target of $22.08.
- Add Wright Medical Group to My Watchlist.